| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/23/2004 | WO2004081036A1 Peptidic antibiotic |
| 09/23/2004 | WO2004081031A2 Thiol-mediated drug attachment to targeting peptides |
| 09/23/2004 | WO2004081030A2 Peptides selectively lethal to malignant and transformed mammalian cells |
| 09/23/2004 | WO2004081024A2 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/23/2004 | WO2004081021A2 Oligonucleotide mimetics |
| 09/23/2004 | WO2004080957A2 Use of adnf polypeptides for treating anxiety and depression |
| 09/23/2004 | WO2004080575A1 Use of recombinant albumin in dialysis after liver failure |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080482A2 Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure |
| 09/23/2004 | WO2004080481A1 Novel nph insulin preparations |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080479A1 Gonadal function improving agents |
| 09/23/2004 | WO2004080478A1 Therapeutic and prophylactic compositions and uses therefor |
| 09/23/2004 | WO2004080477A1 Aplidine for multiple myeloma treatment |
| 09/23/2004 | WO2004080476A1 Use of secretin in the treatment of schizophrenia |
| 09/23/2004 | WO2004080475A1 Composition against infection with rotavirus and process for producing the same |
| 09/23/2004 | WO2004080467A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds |
| 09/23/2004 | WO2004080443A1 Treatment and/or prevention of non-viral epithelial damage |
| 09/23/2004 | WO2004080429A2 Use of thiol-based compositions in ameliorating mucosal injury |
| 09/23/2004 | WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080421A2 Improved antitumoral treatments |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080416A2 Animal model simulating neurologic disease |
| 09/23/2004 | WO2004080412A2 Paclitaxel hybrid derivatives |
| 09/23/2004 | WO2004080408A2 Method of treating cancer with azaspirane compositions |
| 09/23/2004 | WO2004080405A2 Igf-binding protein-derived peptide or small molecule |
| 09/23/2004 | WO2004080404A2 Il-2 transmembrane constructs |
| 09/23/2004 | WO2004080401A2 Oral insulin therapies and protocol |
| 09/23/2004 | WO2004080392A2 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth |
| 09/23/2004 | WO2004080375A2 Vaccine therapy of atherosclerosis |
| 09/23/2004 | WO2004080287A2 Method of killing cancer cells |
| 09/23/2004 | WO2004080283A2 Type 1 ryanodine receptor-based methods |
| 09/23/2004 | WO2004080148A2 Novel nucleic acids and polypeptides |
| 09/23/2004 | WO2004072293A3 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 09/23/2004 | WO2004069993A3 Non-touch zona pellucida microdrilling of a single - cell embryo with a 1.48 um laser beam for introduction of retrovirus |
| 09/23/2004 | WO2004067704A3 Freeze-dried fibrin matrices and methods for preparation thereof |
| 09/23/2004 | WO2004067022A3 Use of a mixture containing neuropeptides and steroids for treating disturbances of psychosocial experiences and behaviour |
| 09/23/2004 | WO2004066914A3 Variant integrin polypeptides and uses thereof |
| 09/23/2004 | WO2004058269A9 Use of gnrh agonists to support the luteal phase during infertility treatment |
| 09/23/2004 | WO2004056853A3 An immunomodulatory protein derived from trypanosomes and uses thereof |
| 09/23/2004 | WO2004052915A3 Novel cyclic peptides comprising alpha-, beta- and gamma- amino acids |
| 09/23/2004 | WO2004052304A3 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 09/23/2004 | WO2004049964A3 Drug to be introduced tooth or periodontal tissue and apparatus for introducing drug to tooth or periodontal tissue |
| 09/23/2004 | WO2004047735A3 Broad spectrum anti-viral therapeutics and prophylaxis |
| 09/23/2004 | WO2004047733A3 Anti-tumor metallocomplexes of crude extract from canavalia ensiformis |
| 09/23/2004 | WO2004043404A3 Process for designing inhibitors of influenza virus non-structural protein 1 |
| 09/23/2004 | WO2004042024A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF HIF-1 ALPHA |
| 09/23/2004 | WO2004041155A3 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 09/23/2004 | WO2004039430A3 Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x |
| 09/23/2004 | WO2004037858A3 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof |
| 09/23/2004 | WO2004035082A3 Proteins involved in the regulation of energy homeostasis |
| 09/23/2004 | WO2004035011A3 Botulinum toxin dental therapies and procedures |
| 09/23/2004 | WO2004029215A3 Conditional gene expression using rnai |
| 09/23/2004 | WO2004028444A3 Parathyroid hormone antagonists and uses thereof |
| 09/23/2004 | WO2004024877A3 Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 09/23/2004 | WO2004020593A3 Immune response associated proteins |
| 09/23/2004 | WO2004020577A3 Processes for inhibiting gene expression using polynucleotides |
| 09/23/2004 | WO2004019921A3 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 09/23/2004 | WO2004016744A3 Treatment of liver deseases |
| 09/23/2004 | WO2004013300A3 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 09/23/2004 | WO2004007671A3 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 09/23/2004 | WO2003104395A3 Receptors and membrane-associated proteins |
| 09/23/2004 | WO2003104273A3 Therapeutic epitopes and uses thereof |
| 09/23/2004 | WO2003100439A3 Receptor and screening methods |
| 09/23/2004 | WO2003095611A3 Androgen-regulated pmepa1 and cancer |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003093294A3 Conformationally constrained peptides that bind the orl-1 receptor |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/23/2004 | WO2003079403A3 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
| 09/23/2004 | WO2003078601A3 Posh nucleic acids, polypeptides and related methods |
| 09/23/2004 | WO2003076647A3 Jade nucleic acids, proteins and uses thereof |
| 09/23/2004 | WO2003072017A3 Macromolecular conjugates and processes for preparing same |
| 09/23/2004 | WO2003064449A3 Bioactive keratin peptides |
| 09/23/2004 | WO2003063782A3 Kappa-pviia-related conotoxins as organ protectants |
| 09/23/2004 | WO2003061681A3 Proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/23/2004 | WO2003059436A3 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 09/23/2004 | WO2003043518A3 Methods and products for oral care |
| 09/23/2004 | WO2003024410A3 Composition for treating streptococcus pneumoniae |
| 09/23/2004 | WO2003005956A3 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 09/23/2004 | WO2002095003A3 Phytases, nucleic acids encoding them and methods for making and using them |
| 09/23/2004 | WO2002094988A3 Lipid-associated molecules |
| 09/23/2004 | WO2002086124A8 Human chemokine-13 |
| 09/23/2004 | US20040186423 Systems and methods for treating ischemia |
| 09/23/2004 | US20040186421 Controlled enzymatic removal and retrieval of cells |
| 09/23/2004 | US20040186287 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 09/23/2004 | US20040186277 Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186274 Methylation of histone h4 at arginine 3 |
| 09/23/2004 | US20040186273 Prion-binding ligands and methods of using same |
| 09/23/2004 | US20040186272 Comprises microbiocidal cationic amino acid sequence for prevention of respiratory and pulmonary infections |
| 09/23/2004 | US20040186271 Thrombin generation inhibitors |
| 09/23/2004 | US20040186164 Pharmaceutical composition comprising citrulline |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186121 Tamper-resistant oral opioid agonist formulations |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186071 Oligonucleotides or polynucleotides; screening for a drug candidate of an immunomodulator for CD40; reducing IL-12 cytokine production, treating inflammation disease; peptide nucleotide acid, modified nucleotides |
| 09/23/2004 | US20040186069 Antisense modulation of tumor necrosis factor receptor 2 expression |
| 09/23/2004 | US20040186068 Introduction of an alteration to the polypeptide to form an altered polypeptide; the assembly of a multiplicity of transcriptional regulatory factors on the altered polypeptide to form a controllable platform; and the specific targeting of the controllable platform to a plurality of promoters |
| 09/23/2004 | US20040186059 Method for treating conditions associated with the Metabolic Syndrome (Syndrome X) |